http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
-
Todos Medical CEO to Appear on Fox Business to Talk COVID Testing & Tollovir on Tuesday, January 11, 2022 and is Presenting at Biotech Showcase 2022
-
CEO Presenting on the Emerging Growth Conference on January 5 Register Now
-
CEOs Presenting at the Emerging Growth Conference on December 8; Register Now
-
Todos Medical Announces 90-Day Moratorium on Conversions of Convertible Notes and Lockup of Common Stock Sales with Convertible Note Holders
-
CEO Presenting on the Emerging Growth Conference on September 15. Register Now
-
CEO Presenting on the Emerging Growth Conference on August 18. Register Now
-
CEO Presenting on the Emerging Growth / Investors Hub Joint Conference on July 7. Register Now
-
CEO Presenting on the Emerging Growth Conference on April 28. Register here
-
Amarantus Releases Letter to Shareholders
-
Todos Medical Exercises Option to Acquire Remaining 80.01% of Breakthrough Diagnostics from Amarantus After Review of Alzheimer's Blood Test Data
-
Todos and Amarantus Announce Completion of LymPro PET 1 Study by Leipzig University for Alzheimer’s Blood Diagnostic LymPro Test 2.0
-
Todos Medical Raises $1,350,500 In Funding and Finalizes Joint Venture Agreement with Amarantus Bioscience
-
Amarantus Provides 2019 Roadmap
-
Todos Medical Enters into Joint Venture Agreement with Amarantus to develop Alzheimer’s Blood Diagnostic LymPro Test 2.0
